Development
GE HealthCare Technologies Inc.
GEHC
$71.62
$0.070.10%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 5.21B | 4.82B | 4.82B | 4.71B | 4.94B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.21B | 4.82B | 4.82B | 4.71B | 4.94B |
| Cost of Revenue | 3.05B | 2.89B | 2.88B | 2.82B | 3.01B |
| Gross Profit | 2.16B | 1.94B | 1.94B | 1.89B | 1.93B |
| SG&A Expenses | 994.00M | 879.00M | 972.00M | 968.00M | 880.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.36B | 4.09B | 4.15B | 4.05B | 4.16B |
| Operating Income | 847.00M | 734.00M | 670.00M | 653.00M | 781.00M |
| Income Before Tax | 609.00M | 636.00M | 570.00M | 546.00M | 718.00M |
| Income Tax Expenses | 193.00M | 250.00M | 137.00M | 163.00M | 151.00M |
| Earnings from Continuing Operations | 416.00M | 386.00M | 433.00M | 383.00M | 567.00M |
| Earnings from Discontinued Operations | 0.00 | -4.00M | -- | -- | 6.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.00M | -7.00M | -15.00M | -11.00M | -19.00M |
| Net Income | 403.00M | 375.00M | 418.00M | 372.00M | 554.00M |
| EBIT | 847.00M | 734.00M | 670.00M | 653.00M | 781.00M |
| EBITDA | 991.00M | 887.00M | 826.00M | 810.00M | 938.00M |
| EPS Basic | 0.89 | 0.82 | 0.92 | 0.42 | 1.22 |
| Normalized Basic EPS | 0.78 | 0.88 | 0.75 | 0.73 | 0.95 |
| EPS Diluted | 0.88 | 0.82 | 0.91 | 0.42 | 1.22 |
| Normalized Diluted EPS | 0.78 | 0.88 | 0.75 | 0.72 | 0.95 |
| Average Basic Shares Outstanding | 455.00M | 455.00M | 455.00M | 455.00M | 454.00M |
| Average Diluted Shares Outstanding | 458.00M | 458.00M | 458.00M | 458.00M | 454.00M |
| Dividend Per Share | 0.03 | 0.03 | 0.03 | 0.03 | -- |
| Payout Ratio | 3.23% | -- | 3.35% | -- | -- |